nodes	percent_of_prediction	percent_of_DWPC	metapath
Clindamycin—CYP3A4—breast cancer	0.322	1	CbGaD
Clindamycin—CYP3A4—Exemestane—breast cancer	0.062	0.133	CbGbCtD
Clindamycin—CYP3A4—Letrozole—breast cancer	0.0527	0.113	CbGbCtD
Clindamycin—CYP3A4—Anastrozole—breast cancer	0.047	0.101	CbGbCtD
Clindamycin—CYP3A4—Toremifene—breast cancer	0.043	0.0921	CbGbCtD
Clindamycin—CYP3A4—Fulvestrant—breast cancer	0.04	0.0856	CbGbCtD
Clindamycin—CYP3A4—Thiotepa—breast cancer	0.0356	0.0763	CbGbCtD
Clindamycin—CYP3A4—Ixabepilone—breast cancer	0.0326	0.0698	CbGbCtD
Clindamycin—CYP3A4—Lapatinib—breast cancer	0.0314	0.0672	CbGbCtD
Clindamycin—CYP3A4—Raloxifene—breast cancer	0.0238	0.0509	CbGbCtD
Clindamycin—CYP3A4—Vinorelbine—breast cancer	0.0174	0.0372	CbGbCtD
Clindamycin—CYP3A4—Tamoxifen—breast cancer	0.0157	0.0336	CbGbCtD
Clindamycin—CYP3A4—Mitoxantrone—breast cancer	0.0153	0.0328	CbGbCtD
Clindamycin—CYP3A4—Paclitaxel—breast cancer	0.0122	0.0262	CbGbCtD
Clindamycin—CYP3A4—Irinotecan—breast cancer	0.0121	0.0258	CbGbCtD
Clindamycin—CYP3A4—Vinblastine—breast cancer	0.0107	0.023	CbGbCtD
Clindamycin—CYP3A4—Docetaxel—breast cancer	0.00883	0.0189	CbGbCtD
Clindamycin—CYP3A4—Doxorubicin—breast cancer	0.00659	0.0141	CbGbCtD
Clindamycin—Abdominal pain—Mitoxantrone—breast cancer	6.34e-05	0.000301	CcSEcCtD
Clindamycin—Body temperature increased—Irinotecan—breast cancer	6.34e-05	0.000301	CcSEcCtD
Clindamycin—Body temperature increased—Mitoxantrone—breast cancer	6.34e-05	0.000301	CcSEcCtD
Clindamycin—Abdominal pain—Irinotecan—breast cancer	6.34e-05	0.000301	CcSEcCtD
Clindamycin—Toxic epidermal necrolysis—Doxorubicin—breast cancer	6.34e-05	0.000301	CcSEcCtD
Clindamycin—Muscle spasms—Capecitabine—breast cancer	6.33e-05	0.0003	CcSEcCtD
Clindamycin—Anaemia—Docetaxel—breast cancer	6.28e-05	0.000298	CcSEcCtD
Clindamycin—Stevens-Johnson syndrome—Methotrexate—breast cancer	6.21e-05	0.000295	CcSEcCtD
Clindamycin—Vomiting—Vinorelbine—breast cancer	6.19e-05	0.000293	CcSEcCtD
Clindamycin—Body temperature increased—Gemcitabine—breast cancer	6.18e-05	0.000293	CcSEcCtD
Clindamycin—Dysuria—Epirubicin—breast cancer	6.15e-05	0.000292	CcSEcCtD
Clindamycin—Neutropenia—Epirubicin—breast cancer	6.15e-05	0.000292	CcSEcCtD
Clindamycin—Dizziness—Thiotepa—breast cancer	6.14e-05	0.000291	CcSEcCtD
Clindamycin—Rash—Vinorelbine—breast cancer	6.13e-05	0.000291	CcSEcCtD
Clindamycin—Dermatitis—Vinorelbine—breast cancer	6.13e-05	0.000291	CcSEcCtD
Clindamycin—Abdominal distension—Doxorubicin—breast cancer	6.13e-05	0.000291	CcSEcCtD
Clindamycin—Hypotension—Paclitaxel—breast cancer	6.11e-05	0.00029	CcSEcCtD
Clindamycin—Upper respiratory tract infection—Epirubicin—breast cancer	6.11e-05	0.00029	CcSEcCtD
Clindamycin—Urticaria—Fluorouracil—breast cancer	6.1e-05	0.00029	CcSEcCtD
Clindamycin—Headache—Vinorelbine—breast cancer	6.09e-05	0.000289	CcSEcCtD
Clindamycin—Leukopenia—Docetaxel—breast cancer	6.08e-05	0.000289	CcSEcCtD
Clindamycin—Anaemia—Capecitabine—breast cancer	6.08e-05	0.000288	CcSEcCtD
Clindamycin—Body temperature increased—Fluorouracil—breast cancer	6.07e-05	0.000288	CcSEcCtD
Clindamycin—Eosinophilia—Doxorubicin—breast cancer	6.03e-05	0.000286	CcSEcCtD
Clindamycin—Photosensitivity reaction—Epirubicin—breast cancer	6e-05	0.000285	CcSEcCtD
Clindamycin—Epistaxis—Methotrexate—breast cancer	5.91e-05	0.00028	CcSEcCtD
Clindamycin—Vertigo—Capecitabine—breast cancer	5.91e-05	0.00028	CcSEcCtD
Clindamycin—Hypersensitivity—Mitoxantrone—breast cancer	5.91e-05	0.00028	CcSEcCtD
Clindamycin—Hypersensitivity—Irinotecan—breast cancer	5.91e-05	0.00028	CcSEcCtD
Clindamycin—Vomiting—Thiotepa—breast cancer	5.91e-05	0.00028	CcSEcCtD
Clindamycin—Leukopenia—Capecitabine—breast cancer	5.89e-05	0.000279	CcSEcCtD
Clindamycin—Hypertension—Docetaxel—breast cancer	5.87e-05	0.000278	CcSEcCtD
Clindamycin—Rash—Thiotepa—breast cancer	5.86e-05	0.000278	CcSEcCtD
Clindamycin—Dermatitis—Thiotepa—breast cancer	5.85e-05	0.000278	CcSEcCtD
Clindamycin—Agranulocytosis—Methotrexate—breast cancer	5.85e-05	0.000277	CcSEcCtD
Clindamycin—Dyspnoea—Paclitaxel—breast cancer	5.83e-05	0.000277	CcSEcCtD
Clindamycin—Headache—Thiotepa—breast cancer	5.82e-05	0.000276	CcSEcCtD
Clindamycin—Stevens-Johnson syndrome—Epirubicin—breast cancer	5.82e-05	0.000276	CcSEcCtD
Clindamycin—Nausea—Vinorelbine—breast cancer	5.78e-05	0.000274	CcSEcCtD
Clindamycin—Dyspepsia—Paclitaxel—breast cancer	5.76e-05	0.000273	CcSEcCtD
Clindamycin—Asthenia—Mitoxantrone—breast cancer	5.76e-05	0.000273	CcSEcCtD
Clindamycin—Asthenia—Irinotecan—breast cancer	5.76e-05	0.000273	CcSEcCtD
Clindamycin—Jaundice—Epirubicin—breast cancer	5.72e-05	0.000271	CcSEcCtD
Clindamycin—Urinary tract infection—Epirubicin—breast cancer	5.7e-05	0.00027	CcSEcCtD
Clindamycin—Dysuria—Doxorubicin—breast cancer	5.69e-05	0.00027	CcSEcCtD
Clindamycin—Neutropenia—Doxorubicin—breast cancer	5.69e-05	0.00027	CcSEcCtD
Clindamycin—Hypertension—Capecitabine—breast cancer	5.68e-05	0.000269	CcSEcCtD
Clindamycin—Hypersensitivity—Fluorouracil—breast cancer	5.66e-05	0.000269	CcSEcCtD
Clindamycin—Upper respiratory tract infection—Doxorubicin—breast cancer	5.66e-05	0.000268	CcSEcCtD
Clindamycin—Gastrointestinal disorder—Paclitaxel—breast cancer	5.65e-05	0.000268	CcSEcCtD
Clindamycin—Fatigue—Paclitaxel—breast cancer	5.64e-05	0.000268	CcSEcCtD
Clindamycin—Asthenia—Gemcitabine—breast cancer	5.61e-05	0.000266	CcSEcCtD
Clindamycin—Constipation—Paclitaxel—breast cancer	5.6e-05	0.000265	CcSEcCtD
Clindamycin—Pain—Paclitaxel—breast cancer	5.6e-05	0.000265	CcSEcCtD
Clindamycin—Photosensitivity reaction—Doxorubicin—breast cancer	5.56e-05	0.000264	CcSEcCtD
Clindamycin—Anaphylactic shock—Docetaxel—breast cancer	5.55e-05	0.000263	CcSEcCtD
Clindamycin—Discomfort—Capecitabine—breast cancer	5.53e-05	0.000263	CcSEcCtD
Clindamycin—Epistaxis—Epirubicin—breast cancer	5.53e-05	0.000262	CcSEcCtD
Clindamycin—Pruritus—Gemcitabine—breast cancer	5.53e-05	0.000262	CcSEcCtD
Clindamycin—Nausea—Thiotepa—breast cancer	5.52e-05	0.000262	CcSEcCtD
Clindamycin—Diarrhoea—Irinotecan—breast cancer	5.49e-05	0.00026	CcSEcCtD
Clindamycin—Diarrhoea—Mitoxantrone—breast cancer	5.49e-05	0.00026	CcSEcCtD
Clindamycin—Agranulocytosis—Epirubicin—breast cancer	5.47e-05	0.00026	CcSEcCtD
Clindamycin—Pruritus—Fluorouracil—breast cancer	5.44e-05	0.000258	CcSEcCtD
Clindamycin—Thrombocytopenia—Docetaxel—breast cancer	5.43e-05	0.000258	CcSEcCtD
Clindamycin—Stevens-Johnson syndrome—Doxorubicin—breast cancer	5.38e-05	0.000255	CcSEcCtD
Clindamycin—Gastrointestinal pain—Paclitaxel—breast cancer	5.35e-05	0.000254	CcSEcCtD
Clindamycin—Diarrhoea—Gemcitabine—breast cancer	5.35e-05	0.000254	CcSEcCtD
Clindamycin—Erythema multiforme—Methotrexate—breast cancer	5.32e-05	0.000252	CcSEcCtD
Clindamycin—Dizziness—Irinotecan—breast cancer	5.31e-05	0.000252	CcSEcCtD
Clindamycin—Jaundice—Doxorubicin—breast cancer	5.29e-05	0.000251	CcSEcCtD
Clindamycin—Urinary tract infection—Doxorubicin—breast cancer	5.28e-05	0.00025	CcSEcCtD
Clindamycin—Diarrhoea—Fluorouracil—breast cancer	5.26e-05	0.000249	CcSEcCtD
Clindamycin—Thrombocytopenia—Capecitabine—breast cancer	5.26e-05	0.000249	CcSEcCtD
Clindamycin—Urticaria—Paclitaxel—breast cancer	5.2e-05	0.000247	CcSEcCtD
Clindamycin—Hypotension—Docetaxel—breast cancer	5.18e-05	0.000246	CcSEcCtD
Clindamycin—Body temperature increased—Paclitaxel—breast cancer	5.17e-05	0.000245	CcSEcCtD
Clindamycin—Abdominal pain—Paclitaxel—breast cancer	5.17e-05	0.000245	CcSEcCtD
Clindamycin—Epistaxis—Doxorubicin—breast cancer	5.12e-05	0.000243	CcSEcCtD
Clindamycin—Vomiting—Irinotecan—breast cancer	5.1e-05	0.000242	CcSEcCtD
Clindamycin—Vomiting—Mitoxantrone—breast cancer	5.1e-05	0.000242	CcSEcCtD
Clindamycin—Dizziness—Fluorouracil—breast cancer	5.08e-05	0.000241	CcSEcCtD
Clindamycin—Agranulocytosis—Doxorubicin—breast cancer	5.06e-05	0.00024	CcSEcCtD
Clindamycin—Rash—Irinotecan—breast cancer	5.06e-05	0.00024	CcSEcCtD
Clindamycin—Rash—Mitoxantrone—breast cancer	5.06e-05	0.00024	CcSEcCtD
Clindamycin—Dermatitis—Mitoxantrone—breast cancer	5.05e-05	0.00024	CcSEcCtD
Clindamycin—Dermatitis—Irinotecan—breast cancer	5.05e-05	0.00024	CcSEcCtD
Clindamycin—Headache—Irinotecan—breast cancer	5.03e-05	0.000238	CcSEcCtD
Clindamycin—Headache—Mitoxantrone—breast cancer	5.03e-05	0.000238	CcSEcCtD
Clindamycin—Hypotension—Capecitabine—breast cancer	5.02e-05	0.000238	CcSEcCtD
Clindamycin—Erythema multiforme—Epirubicin—breast cancer	4.98e-05	0.000236	CcSEcCtD
Clindamycin—Vomiting—Gemcitabine—breast cancer	4.97e-05	0.000236	CcSEcCtD
Clindamycin—Dyspnoea—Docetaxel—breast cancer	4.94e-05	0.000235	CcSEcCtD
Clindamycin—Rash—Gemcitabine—breast cancer	4.93e-05	0.000234	CcSEcCtD
Clindamycin—Dermatitis—Gemcitabine—breast cancer	4.92e-05	0.000234	CcSEcCtD
Clindamycin—Erythema—Methotrexate—breast cancer	4.9e-05	0.000232	CcSEcCtD
Clindamycin—Headache—Gemcitabine—breast cancer	4.9e-05	0.000232	CcSEcCtD
Clindamycin—Flushing—Epirubicin—breast cancer	4.89e-05	0.000232	CcSEcCtD
Clindamycin—Vomiting—Fluorouracil—breast cancer	4.89e-05	0.000232	CcSEcCtD
Clindamycin—Dyspepsia—Docetaxel—breast cancer	4.88e-05	0.000232	CcSEcCtD
Clindamycin—Rash—Fluorouracil—breast cancer	4.85e-05	0.00023	CcSEcCtD
Clindamycin—Dermatitis—Fluorouracil—breast cancer	4.84e-05	0.00023	CcSEcCtD
Clindamycin—Hypersensitivity—Paclitaxel—breast cancer	4.82e-05	0.000229	CcSEcCtD
Clindamycin—Headache—Fluorouracil—breast cancer	4.81e-05	0.000228	CcSEcCtD
Clindamycin—Dysgeusia—Methotrexate—breast cancer	4.8e-05	0.000228	CcSEcCtD
Clindamycin—Gastrointestinal disorder—Docetaxel—breast cancer	4.79e-05	0.000227	CcSEcCtD
Clindamycin—Dyspnoea—Capecitabine—breast cancer	4.79e-05	0.000227	CcSEcCtD
Clindamycin—Fatigue—Docetaxel—breast cancer	4.78e-05	0.000227	CcSEcCtD
Clindamycin—Nausea—Irinotecan—breast cancer	4.77e-05	0.000226	CcSEcCtD
Clindamycin—Nausea—Mitoxantrone—breast cancer	4.77e-05	0.000226	CcSEcCtD
Clindamycin—Constipation—Docetaxel—breast cancer	4.74e-05	0.000225	CcSEcCtD
Clindamycin—Pain—Docetaxel—breast cancer	4.74e-05	0.000225	CcSEcCtD
Clindamycin—Back pain—Methotrexate—breast cancer	4.74e-05	0.000225	CcSEcCtD
Clindamycin—Dyspepsia—Capecitabine—breast cancer	4.73e-05	0.000224	CcSEcCtD
Clindamycin—Asthenia—Paclitaxel—breast cancer	4.69e-05	0.000223	CcSEcCtD
Clindamycin—Nausea—Gemcitabine—breast cancer	4.64e-05	0.00022	CcSEcCtD
Clindamycin—Gastrointestinal disorder—Capecitabine—breast cancer	4.64e-05	0.00022	CcSEcCtD
Clindamycin—Fatigue—Capecitabine—breast cancer	4.63e-05	0.00022	CcSEcCtD
Clindamycin—Pruritus—Paclitaxel—breast cancer	4.63e-05	0.00022	CcSEcCtD
Clindamycin—Erythema multiforme—Doxorubicin—breast cancer	4.61e-05	0.000219	CcSEcCtD
Clindamycin—Pain—Capecitabine—breast cancer	4.59e-05	0.000218	CcSEcCtD
Clindamycin—Constipation—Capecitabine—breast cancer	4.59e-05	0.000218	CcSEcCtD
Clindamycin—Erythema—Epirubicin—breast cancer	4.58e-05	0.000217	CcSEcCtD
Clindamycin—Nausea—Fluorouracil—breast cancer	4.56e-05	0.000217	CcSEcCtD
Clindamycin—Gastrointestinal pain—Docetaxel—breast cancer	4.54e-05	0.000215	CcSEcCtD
Clindamycin—Anaemia—Methotrexate—breast cancer	4.53e-05	0.000215	CcSEcCtD
Clindamycin—Flushing—Doxorubicin—breast cancer	4.52e-05	0.000214	CcSEcCtD
Clindamycin—Flatulence—Epirubicin—breast cancer	4.52e-05	0.000214	CcSEcCtD
Clindamycin—Dysgeusia—Epirubicin—breast cancer	4.49e-05	0.000213	CcSEcCtD
Clindamycin—Diarrhoea—Paclitaxel—breast cancer	4.48e-05	0.000212	CcSEcCtD
Clindamycin—Back pain—Epirubicin—breast cancer	4.43e-05	0.00021	CcSEcCtD
Clindamycin—Muscle spasms—Epirubicin—breast cancer	4.41e-05	0.000209	CcSEcCtD
Clindamycin—Vertigo—Methotrexate—breast cancer	4.4e-05	0.000209	CcSEcCtD
Clindamycin—Gastrointestinal pain—Capecitabine—breast cancer	4.39e-05	0.000208	CcSEcCtD
Clindamycin—Abdominal pain—Docetaxel—breast cancer	4.38e-05	0.000208	CcSEcCtD
Clindamycin—Body temperature increased—Docetaxel—breast cancer	4.38e-05	0.000208	CcSEcCtD
Clindamycin—Leukopenia—Methotrexate—breast cancer	4.38e-05	0.000208	CcSEcCtD
Clindamycin—Dizziness—Paclitaxel—breast cancer	4.33e-05	0.000205	CcSEcCtD
Clindamycin—Urticaria—Capecitabine—breast cancer	4.27e-05	0.000202	CcSEcCtD
Clindamycin—Body temperature increased—Capecitabine—breast cancer	4.24e-05	0.000201	CcSEcCtD
Clindamycin—Abdominal pain—Capecitabine—breast cancer	4.24e-05	0.000201	CcSEcCtD
Clindamycin—Erythema—Doxorubicin—breast cancer	4.24e-05	0.000201	CcSEcCtD
Clindamycin—Anaemia—Epirubicin—breast cancer	4.24e-05	0.000201	CcSEcCtD
Clindamycin—Flatulence—Doxorubicin—breast cancer	4.18e-05	0.000198	CcSEcCtD
Clindamycin—Vomiting—Paclitaxel—breast cancer	4.16e-05	0.000197	CcSEcCtD
Clindamycin—Dysgeusia—Doxorubicin—breast cancer	4.15e-05	0.000197	CcSEcCtD
Clindamycin—Rash—Paclitaxel—breast cancer	4.13e-05	0.000196	CcSEcCtD
Clindamycin—Dermatitis—Paclitaxel—breast cancer	4.12e-05	0.000196	CcSEcCtD
Clindamycin—Discomfort—Methotrexate—breast cancer	4.12e-05	0.000195	CcSEcCtD
Clindamycin—Vertigo—Epirubicin—breast cancer	4.12e-05	0.000195	CcSEcCtD
Clindamycin—Leukopenia—Epirubicin—breast cancer	4.1e-05	0.000195	CcSEcCtD
Clindamycin—Back pain—Doxorubicin—breast cancer	4.1e-05	0.000195	CcSEcCtD
Clindamycin—Headache—Paclitaxel—breast cancer	4.1e-05	0.000194	CcSEcCtD
Clindamycin—Hypersensitivity—Docetaxel—breast cancer	4.09e-05	0.000194	CcSEcCtD
Clindamycin—Muscle spasms—Doxorubicin—breast cancer	4.08e-05	0.000193	CcSEcCtD
Clindamycin—Anaphylactic shock—Methotrexate—breast cancer	4e-05	0.00019	CcSEcCtD
Clindamycin—Asthenia—Docetaxel—breast cancer	3.98e-05	0.000189	CcSEcCtD
Clindamycin—Hypertension—Epirubicin—breast cancer	3.96e-05	0.000188	CcSEcCtD
Clindamycin—Hypersensitivity—Capecitabine—breast cancer	3.96e-05	0.000188	CcSEcCtD
Clindamycin—Pruritus—Docetaxel—breast cancer	3.92e-05	0.000186	CcSEcCtD
Clindamycin—Anaemia—Doxorubicin—breast cancer	3.92e-05	0.000186	CcSEcCtD
Clindamycin—Thrombocytopenia—Methotrexate—breast cancer	3.91e-05	0.000186	CcSEcCtD
Clindamycin—Nausea—Paclitaxel—breast cancer	3.89e-05	0.000184	CcSEcCtD
Clindamycin—Discomfort—Epirubicin—breast cancer	3.86e-05	0.000183	CcSEcCtD
Clindamycin—Asthenia—Capecitabine—breast cancer	3.85e-05	0.000183	CcSEcCtD
Clindamycin—Vertigo—Doxorubicin—breast cancer	3.81e-05	0.000181	CcSEcCtD
Clindamycin—Pruritus—Capecitabine—breast cancer	3.8e-05	0.00018	CcSEcCtD
Clindamycin—Leukopenia—Doxorubicin—breast cancer	3.8e-05	0.00018	CcSEcCtD
Clindamycin—Diarrhoea—Docetaxel—breast cancer	3.79e-05	0.00018	CcSEcCtD
Clindamycin—Anaphylactic shock—Epirubicin—breast cancer	3.74e-05	0.000177	CcSEcCtD
Clindamycin—Hypotension—Methotrexate—breast cancer	3.74e-05	0.000177	CcSEcCtD
Clindamycin—Diarrhoea—Capecitabine—breast cancer	3.67e-05	0.000174	CcSEcCtD
Clindamycin—Dizziness—Docetaxel—breast cancer	3.67e-05	0.000174	CcSEcCtD
Clindamycin—Thrombocytopenia—Epirubicin—breast cancer	3.66e-05	0.000174	CcSEcCtD
Clindamycin—Hypertension—Doxorubicin—breast cancer	3.66e-05	0.000174	CcSEcCtD
Clindamycin—Discomfort—Doxorubicin—breast cancer	3.57e-05	0.000169	CcSEcCtD
Clindamycin—Dyspnoea—Methotrexate—breast cancer	3.56e-05	0.000169	CcSEcCtD
Clindamycin—Dizziness—Capecitabine—breast cancer	3.55e-05	0.000168	CcSEcCtD
Clindamycin—Vomiting—Docetaxel—breast cancer	3.53e-05	0.000167	CcSEcCtD
Clindamycin—Dyspepsia—Methotrexate—breast cancer	3.52e-05	0.000167	CcSEcCtD
Clindamycin—Rash—Docetaxel—breast cancer	3.5e-05	0.000166	CcSEcCtD
Clindamycin—Hypotension—Epirubicin—breast cancer	3.5e-05	0.000166	CcSEcCtD
Clindamycin—Dermatitis—Docetaxel—breast cancer	3.49e-05	0.000166	CcSEcCtD
Clindamycin—Headache—Docetaxel—breast cancer	3.47e-05	0.000165	CcSEcCtD
Clindamycin—Anaphylactic shock—Doxorubicin—breast cancer	3.46e-05	0.000164	CcSEcCtD
Clindamycin—Gastrointestinal disorder—Methotrexate—breast cancer	3.45e-05	0.000164	CcSEcCtD
Clindamycin—Fatigue—Methotrexate—breast cancer	3.45e-05	0.000163	CcSEcCtD
Clindamycin—Pain—Methotrexate—breast cancer	3.42e-05	0.000162	CcSEcCtD
Clindamycin—Vomiting—Capecitabine—breast cancer	3.41e-05	0.000162	CcSEcCtD
Clindamycin—Thrombocytopenia—Doxorubicin—breast cancer	3.39e-05	0.000161	CcSEcCtD
Clindamycin—Rash—Capecitabine—breast cancer	3.39e-05	0.000161	CcSEcCtD
Clindamycin—Dermatitis—Capecitabine—breast cancer	3.38e-05	0.00016	CcSEcCtD
Clindamycin—Headache—Capecitabine—breast cancer	3.36e-05	0.00016	CcSEcCtD
Clindamycin—Dyspnoea—Epirubicin—breast cancer	3.34e-05	0.000158	CcSEcCtD
Clindamycin—Nausea—Docetaxel—breast cancer	3.29e-05	0.000156	CcSEcCtD
Clindamycin—Dyspepsia—Epirubicin—breast cancer	3.29e-05	0.000156	CcSEcCtD
Clindamycin—Gastrointestinal pain—Methotrexate—breast cancer	3.27e-05	0.000155	CcSEcCtD
Clindamycin—Hypotension—Doxorubicin—breast cancer	3.23e-05	0.000153	CcSEcCtD
Clindamycin—Gastrointestinal disorder—Epirubicin—breast cancer	3.23e-05	0.000153	CcSEcCtD
Clindamycin—Fatigue—Epirubicin—breast cancer	3.23e-05	0.000153	CcSEcCtD
Clindamycin—Pain—Epirubicin—breast cancer	3.2e-05	0.000152	CcSEcCtD
Clindamycin—Constipation—Epirubicin—breast cancer	3.2e-05	0.000152	CcSEcCtD
Clindamycin—Nausea—Capecitabine—breast cancer	3.19e-05	0.000151	CcSEcCtD
Clindamycin—Urticaria—Methotrexate—breast cancer	3.18e-05	0.000151	CcSEcCtD
Clindamycin—Abdominal pain—Methotrexate—breast cancer	3.16e-05	0.00015	CcSEcCtD
Clindamycin—Body temperature increased—Methotrexate—breast cancer	3.16e-05	0.00015	CcSEcCtD
Clindamycin—Dyspnoea—Doxorubicin—breast cancer	3.09e-05	0.000146	CcSEcCtD
Clindamycin—Gastrointestinal pain—Epirubicin—breast cancer	3.06e-05	0.000145	CcSEcCtD
Clindamycin—Dyspepsia—Doxorubicin—breast cancer	3.05e-05	0.000145	CcSEcCtD
Clindamycin—Gastrointestinal disorder—Doxorubicin—breast cancer	2.99e-05	0.000142	CcSEcCtD
Clindamycin—Fatigue—Doxorubicin—breast cancer	2.98e-05	0.000142	CcSEcCtD
Clindamycin—Urticaria—Epirubicin—breast cancer	2.97e-05	0.000141	CcSEcCtD
Clindamycin—Constipation—Doxorubicin—breast cancer	2.96e-05	0.00014	CcSEcCtD
Clindamycin—Pain—Doxorubicin—breast cancer	2.96e-05	0.00014	CcSEcCtD
Clindamycin—Body temperature increased—Epirubicin—breast cancer	2.96e-05	0.00014	CcSEcCtD
Clindamycin—Abdominal pain—Epirubicin—breast cancer	2.96e-05	0.00014	CcSEcCtD
Clindamycin—Hypersensitivity—Methotrexate—breast cancer	2.95e-05	0.00014	CcSEcCtD
Clindamycin—Asthenia—Methotrexate—breast cancer	2.87e-05	0.000136	CcSEcCtD
Clindamycin—Gastrointestinal pain—Doxorubicin—breast cancer	2.83e-05	0.000134	CcSEcCtD
Clindamycin—Pruritus—Methotrexate—breast cancer	2.83e-05	0.000134	CcSEcCtD
Clindamycin—Hypersensitivity—Epirubicin—breast cancer	2.76e-05	0.000131	CcSEcCtD
Clindamycin—Urticaria—Doxorubicin—breast cancer	2.75e-05	0.00013	CcSEcCtD
Clindamycin—Abdominal pain—Doxorubicin—breast cancer	2.74e-05	0.00013	CcSEcCtD
Clindamycin—Body temperature increased—Doxorubicin—breast cancer	2.74e-05	0.00013	CcSEcCtD
Clindamycin—Diarrhoea—Methotrexate—breast cancer	2.74e-05	0.00013	CcSEcCtD
Clindamycin—Asthenia—Epirubicin—breast cancer	2.68e-05	0.000127	CcSEcCtD
Clindamycin—Pruritus—Epirubicin—breast cancer	2.65e-05	0.000126	CcSEcCtD
Clindamycin—Dizziness—Methotrexate—breast cancer	2.64e-05	0.000125	CcSEcCtD
Clindamycin—Diarrhoea—Epirubicin—breast cancer	2.56e-05	0.000121	CcSEcCtD
Clindamycin—Hypersensitivity—Doxorubicin—breast cancer	2.55e-05	0.000121	CcSEcCtD
Clindamycin—Vomiting—Methotrexate—breast cancer	2.54e-05	0.000121	CcSEcCtD
Clindamycin—Rash—Methotrexate—breast cancer	2.52e-05	0.00012	CcSEcCtD
Clindamycin—Dermatitis—Methotrexate—breast cancer	2.52e-05	0.000119	CcSEcCtD
Clindamycin—Headache—Methotrexate—breast cancer	2.5e-05	0.000119	CcSEcCtD
Clindamycin—Asthenia—Doxorubicin—breast cancer	2.48e-05	0.000118	CcSEcCtD
Clindamycin—Dizziness—Epirubicin—breast cancer	2.47e-05	0.000117	CcSEcCtD
Clindamycin—Pruritus—Doxorubicin—breast cancer	2.45e-05	0.000116	CcSEcCtD
Clindamycin—Vomiting—Epirubicin—breast cancer	2.38e-05	0.000113	CcSEcCtD
Clindamycin—Nausea—Methotrexate—breast cancer	2.37e-05	0.000113	CcSEcCtD
Clindamycin—Diarrhoea—Doxorubicin—breast cancer	2.37e-05	0.000112	CcSEcCtD
Clindamycin—Rash—Epirubicin—breast cancer	2.36e-05	0.000112	CcSEcCtD
Clindamycin—Dermatitis—Epirubicin—breast cancer	2.36e-05	0.000112	CcSEcCtD
Clindamycin—Headache—Epirubicin—breast cancer	2.34e-05	0.000111	CcSEcCtD
Clindamycin—Dizziness—Doxorubicin—breast cancer	2.29e-05	0.000109	CcSEcCtD
Clindamycin—Nausea—Epirubicin—breast cancer	2.22e-05	0.000105	CcSEcCtD
Clindamycin—Vomiting—Doxorubicin—breast cancer	2.2e-05	0.000104	CcSEcCtD
Clindamycin—Rash—Doxorubicin—breast cancer	2.18e-05	0.000104	CcSEcCtD
Clindamycin—Dermatitis—Doxorubicin—breast cancer	2.18e-05	0.000103	CcSEcCtD
Clindamycin—Headache—Doxorubicin—breast cancer	2.17e-05	0.000103	CcSEcCtD
Clindamycin—Nausea—Doxorubicin—breast cancer	2.06e-05	9.75e-05	CcSEcCtD
